Huang Yen-Ming, Wang Tzu, Yang Yu-Meng, Chang Yung-Hsuan, Chan Hsun-Yu, Lin Hsiang-Wen
Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei City, Taiwan.
School of Pharmacy, College of Medicine, National Taiwan University, Taipei City, Taiwan.
Postgrad Med. 2025 Jan;137(1):68-78. doi: 10.1080/00325481.2024.2444258. Epub 2024 Dec 24.
This study aimed to translate and validate the Adherence to Refills and Medications Scale into Traditional Chinese (ChARMS-T) and to investigate common barriers to medication adherence among patients with type 2 diabetes (T2D) in Taiwan.
The ChARMS-T was developed through translation and application phases. During the translation phase, the scale underwent forward translation, backward translation, and cognitive debriefing. In the application phase, the finalized ChARMS-T was administered to patients with T2D at five Taiwan community pharmacies over eleven months starting in June 2023. Psychometric properties were assessed using criterion validity, construct validity through confirmatory factor analysis, and reliability through McDonald's omega.
A total of 343 participants completed surveys. Factor analysis of the 12-item ChARMS-T revealed two dimensions: medication-taking (8 items) and medication refill (4 items). The instrument demonstrated acceptable internal consistency, with McDonald's omega scores of 0.841 for medication-taking and 0.647 for medication refill. The medication refill subscale showed strong agreement with the objective refill measure, proportion of days covered, with a coefficient of 0.84, suggesting that these measures evaluate similar constructs. Evidence of known-groups validity was demonstrated by a significant difference between ChARMS-T scores and glycemic control ( = 0.047). Patients with good glycemic control had a significantly higher adherence rate to both refills and medication-taking compared to those with poor glycemic control. The most frequently reported barriers to medication-taking were carelessness (55.7%), forgetfulness (54.8%), and frequent dosing intervals (43.1%). For medication refills, 9.6% of the participants identified a lack of planning as the main reason for not refilling their diabetes medications on time, followed by forgetfulness (7.6%).
The ChARMS-T identified a broader range of non-adherence reasons and demonstrated good psychometric properties. It can be integrated into practice settings for screening and follow-up to enhance medication adherence through effective communication between healthcare professionals and patients, ultimately improving long-term patient health outcomes.
本研究旨在将《药物续方与服药依从性量表》翻译成繁体中文(ChARMS-T)并进行验证,并调查台湾2型糖尿病(T2D)患者服药依从性的常见障碍。
ChARMS-T通过翻译和应用阶段开发。在翻译阶段,该量表经历了正向翻译、反向翻译和认知反馈。在应用阶段,从2023年6月开始的11个月里,最终确定的ChARMS-T在台湾的五家社区药房施用于T2D患者。使用效标效度、通过验证性因素分析的结构效度以及通过麦克唐纳ω系数评估心理测量特性。
共有343名参与者完成了调查。对12项ChARMS-T的因素分析揭示了两个维度:服药(8项)和药物续方(4项)。该工具显示出可接受的内部一致性,服药维度的麦克唐纳ω系数为0.841,药物续方维度为0.647。药物续方子量表与客观的续方测量指标“覆盖天数比例”显示出高度一致性,系数为0.84,表明这些测量指标评估的是相似的结构。ChARMS-T得分与血糖控制之间存在显著差异(=0.047),证明了已知群体效度。与血糖控制不佳的患者相比,血糖控制良好的患者在药物续方和服药方面的依从率显著更高。最常报告的服药障碍是粗心(55.7%)、健忘(54.8%)和服药间隔频繁(43.1%)。对于药物续方,9.6%的参与者认为缺乏规划是未按时续方糖尿病药物的主要原因,其次是健忘(7.6%)。
ChARMS-T识别出了更广泛的不依从原因,并显示出良好的心理测量特性。它可以整合到实践环境中用于筛查和随访,通过医护人员与患者之间的有效沟通来提高服药依从性,最终改善患者的长期健康结果。